Literature DB >> 8112254

Determinants of mortality in status epilepticus.

A R Towne1, J M Pellock, D Ko, R J DeLorenzo.   

Abstract

Using univariate and multivariate regression analysis, we studied seizure duration, seizure type, age, etiologies, other clinical features, and mortality among 253 adults with status epilepticus (SE) admitted to the Medical College of Virginia. Cerebral vascular disease and discontinuation of antiepileptic drugs (AEDs) were the most prominent causes of SE, each accounting for approximately 22% of all patients in the series. The other principle etiologies were alcohol withdrawal, idiopathic, anoxia, metabolic disorders, hemorrhage, infection, tumor, drug overdose, and trauma. When the patients were divided into two groups, the group with SE lasting < 1 h had a lower mortality as compared with seizure duration > or = 1 h. Low mortality rates were noted in alcohol and AED discontinuation etiologies. Anoxia and increasing age were significantly correlated with higher mortality. The mortality rates of partial and generalized SE were not significantly different. Race and sex did not affect mortality significantly. Our findings represent the first multivariate analysis of predictive indicators of mortality in SE and demonstrate that specific factors influence mortality rate in SE.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8112254     DOI: 10.1111/j.1528-1157.1994.tb02908.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  128 in total

Review 1.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

2.  Mortality Associated with Status Epilepticus.

Authors:  Jane G. Boggs
Journal:  Epilepsy Curr       Date:  2004-01       Impact factor: 7.500

Review 3.  The utility of EEG, SSEP, and other neurophysiologic tools to guide neurocritical care.

Authors:  Eric S Rosenthal
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

4.  Recent and future advances in the treatment of status epilepticus.

Authors:  Felix Rosenow; Susanne Knake
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

5.  Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.

Authors:  Laxmikant S Deshpande; Sompong Sombati; Robert E Blair; Dawn S Carter; Billy R Martin; Robert J DeLorenzo
Journal:  Neurosci Lett       Date:  2006-11-15       Impact factor: 3.046

6.  EEG 24/7: The Use of Emergency EEG to Diagnose Status Epilepticus.

Authors:  Elizabeth J Waterhouse
Journal:  Epilepsy Curr       Date:  2004-03       Impact factor: 7.500

7.  New treatments for refractory status epilepticus.

Authors:  Elizabeth Waterhouse
Journal:  Epilepsy Curr       Date:  2005 Mar-Apr       Impact factor: 7.500

Review 8.  Recent developments in the diagnosis and treatment of status epilepticus.

Authors:  Megan Selvitelli; Frank W Drislane
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

9.  Inappropriate emergency management of status epilepticus in children contributes to need for intensive care.

Authors:  R F M Chin; L Verhulst; B G R Neville; M J Peters; R C Scott
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

10.  Status epilepticus: Using antioxidant agents as alternative therapies.

Authors:  Liliana Carmona-Aparicio; Cecilia Zavala-Tecuapetla; María Eva González-Trujano; Aristides Iii Sampieri; Hortencia Montesinos-Correa; Leticia Granados-Rojas; Esaú Floriano-Sánchez; Elvia Coballase-Urrutía; Noemí Cárdenas-Rodríguez
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.